Label: INFLAMEX- multivitamin capsule

  • Category: HUMAN PRESCRIPTION DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: unapproved drug other

DISCLAIMER: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

Drug Label Information

Updated June 12, 2024

If you are a consumer or patient please visit this version.

  • DESCRIPTION:

    lnflamex™ is a unique formulation of selected natural ingredients such as Turmeric, Black Pepper, Garlic and Proprietary Extract Blend combined with Niacin and Folate. This potent blend is designed to support your body's response to inflammation and its natural healing processes.

    Each capsule contains:

    Niacin (as Niacinamide) ....……………………………….…......25 mg
    Folate (as L-5-Methyltetrahydrofolate calcium salt) ..........1700 mcg DFE
    (1000 mcg of L-5-Methylfolate)
    Turmeric Root Extract……………………………….…………100 mg
    Garlic Bulb Extract……………………………….…………….. 10 mg
    Pepper Seed Extract……………………………….…………….. 5 mg


    Proprietary Extract Blend ………………………….…………. 400 mg

  • Other Ingredients:

    Magnesium Stearate, Microcrystalline Cellulose, Oryza Sativa (Rice) Starch, Vegetable Capsule.

  • Contraindications:

    This product is contraindicated in patients with a known hypersensitivity to any of the ingredients. lnflamex™ is contraindicated in patients with gastrointestinal conditions, such as gastric ulcers or gastroesophageal reflux disease (GERD), as they may experience irritation or worsening of symptoms due to the presence of ingredients like garlic and black pepper. Patients with blood clotting disorders or who are on anticoagulant therapy should use caution when consuming high doses of ingredients like garlic, turmeric, and black pepper, as they may have mild blood-thinning effects.

  • Warnings:

    Tell your doctor if you have: kidney problems, thyroid disease. This medication should be used as directed during pregnancy or while breast-feeding. Consult your doctor. Administration of folate alone is improper therapy for pernicious anemia and other megaloblastic anemias in which vitamin B12 is deficient.

    Precautions:

    Folate in doses above 0.1 mg daily may obscure pernicious anemia, in that hematologic remission can occur while neurological manifestations remain progressive. There is a potential danger in administering folate to patients with undiagnosed anemia since folate may obscure the diagnosis of pernicious anemia by alleviating the hematologic manifestations of the disease while allowing the neurologic complications to progress. This may result in severe nervous system damage before the correct diagnosis is made. The patient's medical conditions and consumption of other drugs, herbs, and/or supplements should be considered.

  • Pregnancy and Lactation:

    Not recommended for use during pregnancy or lactation without consulting with a healthcare professional.

    For use on the order of a licensed healthcare practitioner.
    If a patient experiences any side effects, call your doctor. To report side effects, call PureTek Corporation at 1-877-921-7873 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

  • Adverse Reactions:

    Allergic reactions to any of the ingredients can occur, ranging from mild skin irritation to severe anaphylaxis in rare cases. Allergic sensitization has been reported following both oral and parenteral administration of folate.


    Niacinamide, a form of niacin, may cause flushing, itching, and tingling sensations in some individuals, particularly when taken in higher doses. This effect is usually harmless but can be uncomfortable. Some individuals may experience gastrointestinal symptoms such as nausea, bloating, or diarrhea, especially when consuming higher doses of certain ingredients like garlic and black pepper. Certain ingredients in the product, such as garlic and black pepper, may interact with medications. Garlic may potentiate the effects of anticoagulant medications, while black pepper may affect the metabolism of certain drugs.

  • Dosage and Administration:

    One (1) lnflamex ™ capsule daily or as directed by a licensed healthcare practitioner. Do not administer to children under the age of 12.

  • How Supplied:

    lnflamex™ are light orange powder with black specks, in vegan hard shell capsules. One bottle contains 30 capsules (NDC 59088-191-54). Dispense in a tight, light-resistant container as defined in the USP/NF with a child resistant closure.

  • Storage:

    Do not use if bottle seal is broken.
    KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN.

    Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature].

  • Inflamex™

    Manufactured in the USA by:

    PureTek Corporation
    Panorama City, CA 91402
    For questions or information
    call toll-free: 877-921-7873

    label

  • INGREDIENTS AND APPEARANCE
    INFLAMEX 
    multivitamin capsule
    Product Information
    Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:59088-191
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    BLACK PEPPER (UNII: KM66971LVF) (BLACK PEPPER - UNII:KM66971LVF) BLACK PEPPER5 mg
    NIACINAMIDE (UNII: 25X51I8RD4) (NIACINAMIDE - UNII:25X51I8RD4) NIACINAMIDE25 mg
    GARLIC (UNII: V1V998DC17) (GARLIC - UNII:V1V998DC17) GARLIC10 mg
    TURMERIC (UNII: 856YO1Z64F) (TURMERIC - UNII:856YO1Z64F) TURMERIC100 mg
    LEVOMEFOLATE CALCIUM (UNII: A9R10K3F2F) (LEVOMEFOLIC ACID - UNII:8S95DH25XC) LEVOMEFOLATE CALCIUM1700 ug
    Inactive Ingredients
    Ingredient NameStrength
    MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)  
    MAGNESIUM STEARATE (UNII: 70097M6I30)  
    GELLAN GUM (LOW ACYL) (UNII: 7593U09I4D)  
    STARCH, RICE (UNII: 4DGK8B7I3S)  
    HYPROMELLOSES (UNII: 3NXW29V3WO)  
    Product Characteristics
    Colororange (Light orange with black specks) Scoreno score
    ShapeCAPSULESize22mm
    FlavorImprint Code
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:59088-191-5430 in 1 BOTTLE; Type 0: Not a Combination Product06/12/2024
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    unapproved drug other06/12/2024
    Labeler - PureTek Corporation (785961046)